Antennova

Antennova Marks Milestone in Cancer Treatment with Promising Early Results from Anti-CD24 Antibody Trial

DOYLESTOWN, PA — In a significant stride toward advancing cancer treatment, Antennova, a clinical-stage biotechnology firm dedicated to oncology, has announced the successful completion of the first dosing cohort in …

Antennova Marks Milestone in Cancer Treatment with Promising Early Results from Anti-CD24 Antibody Trial Read More



Business News